Branded Logo Branded Logo Barrington James strategic solutions Logo Barrington James strategic solutions Logo
    • More

      Featured

      Navigating Cell & Gene Therapy Hiring Trends and the 2026 Outlook.
      Biotechnology
      Navigating Cell & Gene Therapy Hiring Trends and the 2026 Outlook.

       Market Context: From Breakthrough Momentum to Operational Discipline When the fir...

      Brandon Schelkle

      By Brandon Schelkle March 12th, 2026

      Why Life Science Roles Sit Vacant for 78 Days and What It’s Really Costing Your Business
      Why Life Science Roles Sit Vacant for 78 Days and What It’s Really Costing Your Business

      The life sciences industry is currently moving at two quite different speeds. On one hand, i...

      Barrington James

      By Barrington James February 9th, 2026

      Navigating 503B Outsourcing Trends and 2026 Outlook
      Pharmaceutical, CRO, Contract Outsourcing
      Navigating 503B Outsourcing Trends and 2026 Outlook

      The U.S. compounding landscape changed substantially when the United States Pharmacopeia (US...

      Barrington James

      By Barrington James January 28th, 2026

      JP Morgan Healthcare Conference 2026: Cautious Optimism and Strategic Opportunity
      Pharmaceutical, Biotechnology
      JP Morgan Healthcare Conference 2026: Cautious Optimism and Strategic Opportunity January 22nd, 2026
      Barrington James

      By Barrington James January 22nd, 2026

      2025 in Review: Strategic Maturity in Life Sciences
      2025 in Review: Strategic Maturity in Life Sciences December 16th, 2025
      Barrington James

      By Barrington James December 16th, 2025

      Must Read

      Navigating 503B Outsourcing Trends and 2026 Outlook
      Pharmaceutical, CRO, Contract Outsourcing
      Navigating 503B Outsourcing Trends and 2026 Outlook January 28th, 2026
      JP Morgan Healthcare Conference 2026: Cautious Optimism and Strategic Opportunity
      Pharmaceutical, Biotechnology
      JP Morgan Healthcare Conference 2026: Cautious Optimism and Strategic Opportunity January 22nd, 2026
      Beyond “Good Enough”: The New Standard in Diabetes Care
      Medical Device
      Beyond “Good Enough”: The New Standard in Diabetes Care November 18th, 2025

      Must Listen

      View All
      The CEO Series with Selwyn Ho
      The CEO Series with Selwyn Ho February 17th, 2025
      The CEO Series with Jan Thirkettle
      CEO Podcast
      The CEO Series with Jan Thirkettle October 24th, 2024
      The CEO Series with Lisa Anson
      CEO Podcast
      The CEO Series with Lisa Anson September 11th, 2024
      From the Dawn of the Internet and Back Again, by Sebastian Hassinger
      Quantum Podcasts
      From the Dawn of the Internet and Back Again, by Sebastian Hassinger August 7th, 2024
      Unlocking your Potential With Data and AI Innovation
      Quantum Podcasts
      Unlocking your Potential With Data and AI Innovation July 23rd, 2024
      Revolutionizing Radiology with AI
      Quantum Podcasts, AI Podcast
      Revolutionizing Radiology with AI June 18th, 2024
      AI Transforming Biotechnology: Innovation, Insights, and Impact
      Quantum Podcasts
      AI Transforming Biotechnology: Innovation, Insights, and Impact June 17th, 2024
      Unlocking the Power of Imaging: How Yunu is Revolutionizing Clinical Trials with AI
      Quantum Podcasts
      Unlocking the Power of Imaging: How Yunu is Revolutionizing Clinical Trials with AI May 14th, 2024

      More Posts

      View All
      2026 Quantum Salary Benchmarking Guide
      2026 Quantum Salary Benchmarking Guide

      Access the latest salary insights shaping the quantum talent market in 2026 with our in-dept...

      Richard Stevenson

      By Richard Stevenson March 31st, 2026

      Clinical Development Lead Placement for a Rare Paediatric Disease Programme
      Pharmaceutical, Consulting
      Clinical Development Lead Placement for a Rare Paediatric Disease Programme
      Bobby Coxon

      By Bobby Coxon March 24th, 2026

      Why the Latest IPO Wave Won’t Be Won on Science Alone.
      Biotechnology
      Why the Latest IPO Wave Won’t Be Won on Science Alone.
      Barrington James

      By Barrington James March 20th, 2026

      The Peptide Shift Is a Stress Test for 503B Infrastructure
      The Peptide Shift Is a Stress Test for 503B Infrastructure
      Ethan Dumoulin

      By Ethan Dumoulin March 12th, 2026

      Barrington James
      Site by Venn